Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener’s)

References

• Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, et al. Granulomatosis with polyangiitis (Wegener’s): an alternative name for Wegener’s granulomatosis. Ann Rheum Dis 2011;70:704.
   PubMed Web of Science ®Google Scholar
• Kallenberg CG. Pathogenesis of ANCA-associated vasculitides. Ann Rheum Dis 2011;70(Suppl):i59–63.
   Google Scholar
• Godman GC, Churg J. Wegener’s granulomatosis: pathology and review of the literature. AMA Arch Pathol 1954;58:533–53.
   PubMedGoogle Scholar
• Hoffman GS, Kerr GS, Leavitt RY, Hallahan C, Lebovics R, Travis W, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488–98.
   PubMed Web of Science ®Google Scholar
• Brogan P, Eleftheriou D, Dillon M. Small vessel vasculitis. Pediatr Nephrol 2010;25:1025–35.
   PubMedGoogle Scholar
• Holle JU, Gross WL. Neurological involvement in Wegener’s granulomatosis. Curr Opin Rheumatol 2011;23:7–11.
   PubMed Web of Science ®Google Scholar
• Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4–9.
   PubMed Web of Science ®Google Scholar
• Holle JU, Gross WL, Latza U, Nölle B, Ambrosch P, Heller M, et al. Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 2011;63:257–66.
   PubMedGoogle Scholar
• Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Peter H, Raspe H, et al. Effect of Wegener’s granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 2002;47:320–5.
   PubMed Web of Science ®Google Scholar
• Carpenter DM, Thorpe CT, Lewis M, Devellis RF, Hogan SL. Health-related quality of life for patients with vasculitis and their spouses. Arthritis Rheum 2009;61:259–65.
   PubMed Web of Science ®Google Scholar
• Merkel PA, Herlyn K, Mahr AD, Neogi T, Seo P, Walsh M, et al. Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9. J Rheumatol 2009; 36:2362–8.
   Google Scholar
• Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, Paran D, Katz BS, Kivity S, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum 2009;60:1484–7.
   PubMed Web of Science ®Google Scholar
• Proft F, Steinbach S, Schulze-Koops H, Hundt W, Heinrich P, Gruenke M. Gustatory and olfactory function in rheumatoid arthritis. Scand J Rheumatol 2011;40:169–77.
   PubMedGoogle Scholar
• Knopf A, Bas M, Chaker A, Strassen U, Pickhard A, Stark T, et al. Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 2011;50:2029–34.
   PubMed Web of Science ®Google Scholar
• Cannady SB, Batra PS, Koening C, Lorenz RR, Citardi MJ, Langford C, et al. Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope 2009; 119:757–61.
   PubMed Web of Science ®Google Scholar
• Laudien M, Lamprecht P, Hedderich J, Holle J, Ambrosch P. Olfactory dysfunction in Wegener’s granulomatosis. Rhinology 2009;47:254–9.
   PubMedGoogle Scholar
• Göktas O, Cao Van H, Fleiner F, Lacroix JS, Landis BN. Chemosensory function in Wegener’s granulomatosis: a preliminary report. Eur Arch Otorhinolaryngol 2010;267:1089–93.
   PubMedGoogle Scholar
• Fasunla JA, Hundt W, Lutz J, Förger F, Thürmel K, Steinbach S. Evaluation of smell and taste in patients with Wegener’s granulomatosis. Eur Arch Otorhinolaryngol 2012;269:179–86.
   PubMedGoogle Scholar
• Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 1990;33:1101–7.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187–92.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009;68:1827–32.
   PubMed Web of Science ®Google Scholar
• Suppiah R, Mukhtyar C, Flossmann O, Alberici F, Baslund B, Batra R, et al. A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 2011;50:899–905.
   PubMedGoogle Scholar
• de Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease extent index for Wegener’s granulomatosis. Clin Nephrol 2001;55:31–8.
   PubMed Web of Science ®Google Scholar
• Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997;40:371–80.
   PubMed Web of Science ®Google Scholar
• Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007;66:605–17.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009;68:310–17.
   PubMed Web of Science ®Google Scholar
• Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the ‘Sniffin’ Sticks’ including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 2007;264:237–43.
   PubMed Web of Science ®Google Scholar
• Mueller C, Kallert S, Renner B, Stiassny K, Temmel AF, Hummel T, et al. Quantitative assessment of gustatory function in a clinical context using impregnated ‘taste strips’. Rhinology 2003;41:2–6.
   PubMed Web of Science ®Google Scholar
• Sultan B, May LA, Lane AP. The role of TNF-α in inflammatory olfactory loss. Laryngoscope 2011;121:2481–6.
   PubMedGoogle Scholar
• Turner JH, Liang KL, May L, Lane AP. Tumor necrosis factor alpha inhibits olfactory regeneration in a transgenic model of chronic rhinosinusitis-associated olfactory loss. Am J Rhinol Allergy 2010;24:336–40.
   PubMedGoogle Scholar
• Nassonov EL, Samsonov MY, Tilz GP, Beketova TV, Semenkova EN, Baranov A, et al. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener’s granulomatosis. J Rheumatol 1997;24:666–70.
   PubMed Web of Science ®Google Scholar
• Wegener’s Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med 2005;352:351–61.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Luqmani R. Current state of tumour necrosis factor α blockade in Wegener’s granulomatosis. Ann Rheum Dis 2005;64(Suppl 4):iv31–6.
   PubMedGoogle Scholar
• Bae S, Kim YG, Choi J, Hong J, Lee S, Kang T, et al. Elevated interleukin-32 expression in granulomatosis with polyangiitis. Rheumatology (Oxford) 2012;51:1979–88.
   PubMedGoogle Scholar
• Jónasdóttir O, Petersen J, Bendtzen K. Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener’s granulomatosis. APMIS 2001; 109:781–6.
   PubMed Web of Science ®Google Scholar
• Komocsi A, Lamprecht P, Csernok E, Mueller A, Holl-Ulrich K, Seitzer U, et al. Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener’s granulomatosis. Am J Pathol 2002;160:1717–24.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhou M, Brand J, Huang L. Inflammation and taste disorders: mechanisms in taste buds. Ann N Y Acad Sci 2009;1170:596–603.
   PubMedGoogle Scholar
• Tadema H, Abdulahad WH, Stegeman CA, Kallenberg CG, Heeringa P. Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis. PLoS One 2011;6:e24315.
   PubMed Web of Science ®Google Scholar
• Naik BS, Shetty N, Maben EV. Drug-induced taste disorders. Eur J Intern Med 2010;21:240–3.
   PubMedGoogle Scholar
• Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 1994;11:318–77.
   PubMed Web of Science ®Google Scholar
• Doty RL, Shah M, Bromley SM. Drug-induced taste disorders. Drug Saf 2008;31:199–215.
   PubMed Web of Science ®Google Scholar